19th Jan 2005 11:20
Man Financial Limited19 January 2005 Date Of Disclosure: 19/01/05 Fax to 020 7256 9386 (Take Over Panel) and 020 7588 6057 (RNS) FORM 8.1/8.3 Lodge with a RIS or Newstrack and the Takeover Panel. Use separate form for eachclass of securities in which dealings have been made. DISCLOSURE UNDER RULES 8.1(a), 8.1(b)(i) AND 8.3 OF THE CITY CODEON TAKEOVERS AND MERGERS Date of dealing 18/01/05 (1) Name of Company Dealing in OXFORD BIOMEDICA PLC Class of securities ORDINARY SHARES (2) Amount Bought Amount Sold Price (GBP) 350000 0.1896 In addition, MAN FIN LTD have entered into CFD arrangements with it's client'swhich are detailed below. (3) Resultant total of the same class owned or controlled and percentage of class 16,760,800 4.50% (4) Party making disclosure MAN FINANCIAL LIMITED (5) Name of purchaser/vendor (Note1) MAN FINANCIAL LIMITED (6) Reason for disclosure (Note 2) (a) Associate of (i) offeror (Note 3) - NO (b) (i) offeree Company - NO Specify which category or categories of associate (1-8 overleaf) If category (8), explain Rule 8.3 (i.e. disclosure because of ownership or control of 1% or more of theclass of relevant securities dealt in) - YES Signed, for and on behalf of the party named in (4) above Stewart Horner Telephone and extension number 020-7144-4201 Note1. Specify owner, not nominee or vehicle company. If relevant, also identifycontroller of owner, e.g. where an owner normally acts on instructions of acontroller. Note 2. Disclosure might be made for more than one reason; if so, state allreasons. Note 3. Specify which offeror if there is more than one. Note 4. When an arrangement exists with any offeror, with the offeree company orwith an associate of any offeror or of the offeree company in relation torelevant securities, details of such arrangement must be disclosed, as requiredby Note 6 on Rule 8. Note 5. It may be necessary, particularly when disclosing derivativetransactions, to append a sheet to this disclosure form so that all relevantinformation can be given. Note 6. In the case of an average price bargain, each underlying trade should bedisclosed For full details of disclosure requirements, see Rule 8 of the Code. If indoubt, contact the Panel on Takeovers and Mergers, Monitoring Section, Tel. No:020 7638 0129. E-mail:[email protected] NOTES REGARDING DISCLOSURE MAN FIN Ltd is the beneficial owner of 16,760,800 Ordinary Shares in the abovecompany which are held to hedge CFD positions resulting from CFD contracts (seebelow) established between MAN FINANCIAL LIMITED and its clients. A Contract for Difference or CFD is an agreement between two parties toexchange, at the close of the contract, the difference between the opening priceand the closing price, multiplied by the number of reference shares specifiedwithin the contract. The 'reference shares' are the underlying shares specifiedin the CFD. The economic performance of the CFD is determined by the performanceof the underlying reference shares. Although CFDs replicate the price movementof the underlying reference shares,they convey no right or requirement toacquire or deliver the physical shares. The contract value of a CFD is defined as the number of reference sharesspecified in the contract, multiplied by the price of the underlying referenceshare. If a client of Man takes a long position, the customer will make a profitif the contract value increases. Conversely, if a customer of Man Financial Ltd takes a short position, thecustomer will benefit if the contract value falls. The CFD contracts detailed below are open-ended and without predeterminedexpiry/close value DEFINITION OF ASSOCIATE It is not practicable to define associate in terms which would cover all thedifferent relationships which may exist in an offer. The term associate is intended to cover all persons (whether or not acting inconcert) who directly or indirectly own or deal in the shares of an offeror orthe offeree company in an offer and who have (in addition to their normalinterests as shareholders) an interest or potential interest, whethercommercial, financial or personal, in the outcome of the offer Without prejudice to the generality of the foregoing, the term associate willnormally include the following:- (1) an offeror's or the offeree company's parent, subsidiaries and fellowsubsidiaries, and their associated companies, and companies of which suchcompanies are associated companies (for this purpose ownership or control of 20%or more of the equity share capital of a company is regarded as the test ofassociated company status); (2) banks and financial and other professional advisers (includingstockbrokers)* to an offeror, the offeree company or any company covered in (1),including persons controlling#, controlled by or under the same control as suchbanks, financial and other professional advisers; (3) the directors (together with their close relatives & related trusts) of anofferor, the offeree company or any company covered in (1); (4) the pension funds of an offeror, the offeree company or any company coveredin (1); (5) any investment company, unit trust or other person whose investments anassociate manages on a discretionary basis, in respect of the relevantinvestment accounts; (6) a person who owns or controls 5% or more of any class of relevant securities(as defined in paragraphs (a) to (d) in Note 2 on Rule 8) issued by an offeroror an offeree company, including a person who as a result of any transactionowns or controls 5% or more. When two or more persons act pursuant to anagreement or understanding (formal or informal) to acquire or control suchsecurities, they will be deemed to be a single person for the purpose of thisparagraph. Such securities managed on a discretionary basis by an investmentmanagement group will, unless otherwise agreed by the Panel, also be deemed tobe those of a single person (see Note 8 on Rule 8); and (7) a company having a material trading arrangement with an offeror or theofferee company. Paragraphs (1)-(7) are typical cases. Paragraph (8) below is a category to coverassociate status not within (1) -(7). (8) Other. CFD OPEN INTEREST PRODUCT NAME EXECUTED MAN FIN No. of PRICE (GBP) LTD Ref Shares OXFORD BIOMEDICA PLC 18/01/05 SALE 350,000 0.1896 LONG CFD OXFORD BIOMEDICA PLC 18/11/04 SALE 100,000 0.1788 LONG CFD OXFORD BIOMEDICA PLC 16/11/04 SALE 100,000 0.1850 LONG CFD OXFORD BIOMEDICA PLC 05/11/04 SALE 100,000 0.2088 LONG CFD OXFORD BIOMEDICA PLC 29/10/04 SALE 3,250,000 0.1925 LONG CFD OXFORD BIOMEDICA PLC 29/10/04 SALE 100,000 0.1888 LONG CFD OXFORD BIOMEDICA PLC 08/10/04 SALE 100,000 0.2025 LONG CFD OXFORD BIOMEDICA PLC 07/10/04 SALE 200,000 0.2000 LONG CFD OXFORD BIOMEDICA PLC 06/10/04 SALE 25,000 0.1850 LONG CFD OXFORD BIOMEDICA PLC 05/10/04 SALE 550,000 0.1950 LONG CFD OXFORD BIOMEDICA PLC 04/10/04 SALE 250,000 0.1875 LONG CFD OXFORD BIOMEDICA PLC 04/10/04 SALE 30,000 0.1800 LONG CFD OXFORD BIOMEDICA PLC 01/10/04 SALE 250,000 0.1700 LONG CFD OXFORD BIOMEDICA PLC 01/10/04 SALE 500,000 0.1675 LONG CFD OXFORD BIOMEDICA PLC 30/09/04 SALE 200,000 0.1650 LONG CFD OXFORD BIOMEDICA PLC 30/09/04 SALE 100,000 0.1625 LONG CFD OXFORD BIOMEDICA PLC 30/09/04 SALE 50,000 0.1675 LONG CFD OXFORD BIOMEDICA PLC 29/09/04 SALE 17,200 0.1600 LONG CFD OXFORD BIOMEDICA PLC 17/09/04 SALE 100,000 0.1750 LONG CFD OXFORD BIOMEDICA PLC 16/09/04 SALE 100,000 0.1540 LONG CFD OXFORD BIOMEDICA PLC 16/09/04 SALE 200,000 0.1700 LONG CFD OXFORD BIOMEDICA PLC 16/09/04 SALE 150,000 0.1650 LONG CFD OXFORD BIOMEDICA PLC 02/09/04 SALE 50,000 0.1600 LONG CFD OXFORD BIOMEDICA PLC 25/08/04 SALE 10,000 0.1450 LONG CFD OXFORD BIOMEDICA PLC 17/08/04 SALE 10,000 0.1525 LONG CFD OXFORD BIOMEDICA PLC 16/08/04 SALE 100,000 0.1550 LONG CFD OXFORD BIOMEDICA PLC 05/07/04 SALE 50,000 0.1965 LONG CFD OXFORD BIOMEDICA PLC 24/06/04 SALE 150,000 0.1950 LONG CFD OXFORD BIOMEDICA PLC 22/06/04 SALE 100,000 0.1900 LONG CFD OXFORD BIOMEDICA PLC 21/06/04 SALE 100,000 0.1900 LONG CFD OXFORD BIOMEDICA PLC 08/06/04 SALE 100,000 0.1995 LONG CFD OXFORD BIOMEDICA PLC 04/06/04 SALE 100,000 0.1975 LONG CFD OXFORD BIOMEDICA PLC 04/06/04 SALE 370,000 0.1925 LONG CFD OXFORD BIOMEDICA PLC 03/06/04 SALE 25,000 0.1975 LONG CFD OXFORD BIOMEDICA PLC 02/06/04 SALE 30,000 0.1925 LONG CFD OXFORD BIOMEDICA PLC 28/05/04 SALE 225,000 0.1690 LONG CFD OXFORD BIOMEDICA PLC 13/05/04 SALE 375,000 0.1750 LONG CFD OXFORD BIOMEDICA PLC 23/04/04 SALE 50,000 0.2125 LONG CFD OXFORD BIOMEDICA PLC 13/04/04 SALE 50,000 0.1925 LONG CFD OXFORD BIOMEDICA PLC 08/04/04 SALE 100,000 0.1975 LONG CFD OXFORD BIOMEDICA PLC 30/03/04 SALE 100,000 0.2375 LONG CFD OXFORD BIOMEDICA PLC 24/03/04 SALE 250,000 0.2375 LONG CFD OXFORD BIOMEDICA PLC 24/03/04 SALE 2 0.2335 LONG CFD OXFORD BIOMEDICA PLC 22/03/04 SALE 150,000 0.2475 LONG CFD OXFORD BIOMEDICA PLC 18/03/04 SALE 50,000 0.2450 LONG CFD OXFORD BIOMEDICA PLC 11/03/04 SALE 100,000 0.2438 LONG CFD OXFORD BIOMEDICA PLC 11/03/04 SALE 100,000 0.2400 LONG CFD OXFORD BIOMEDICA PLC 11/03/04 SALE 50,000 0.2475 LONG CFD OXFORD BIOMEDICA PLC 11/03/04 SALE 100,000 0.2525 LONG CFD OXFORD BIOMEDICA PLC 03/03/04 SALE 200,000 0.2700 LONG CFD OXFORD BIOMEDICA PLC 03/03/04 SALE 50,000 0.2675 LONG CFD OXFORD BIOMEDICA PLC 02/03/04 SALE 50,000 0.2900 LONG CFD OXFORD BIOMEDICA PLC 01/03/04 SALE 100,000 0.2840 LONG CFD OXFORD BIOMEDICA PLC 27/02/04 SALE 10,000 0.2800 LONG CFD OXFORD BIOMEDICA PLC 26/02/04 SALE 100,000 0.2650 LONG CFD OXFORD BIOMEDICA PLC 26/02/04 SALE 50,000 0.2700 LONG CFD OXFORD BIOMEDICA PLC 23/02/04 SALE 25,000 0.2775 LONG CFD OXFORD BIOMEDICA PLC 23/02/04 SALE 50,000 0.2950 LONG CFD OXFORD BIOMEDICA PLC 19/02/04 SALE 450,000 0.2850 LONG CFD OXFORD BIOMEDICA PLC 18/02/04 SALE 200,000 0.2850 LONG CFD OXFORD BIOMEDICA PLC 17/02/04 SALE 65,000 0.2825 LONG CFD OXFORD BIOMEDICA PLC 12/02/04 SALE 250,000 0.2840 LONG CFD OXFORD BIOMEDICA PLC 11/02/04 SALE 100,000 0.2875 LONG CFD OXFORD BIOMEDICA PLC 11/02/04 SALE 25,000 0.2950 LONG CFD OXFORD BIOMEDICA PLC 10/02/04 SALE 300,000 0.2712 LONG CFD OXFORD BIOMEDICA PLC 10/02/04 SALE 100,000 0.2575 LONG CFD OXFORD BIOMEDICA PLC 10/02/04 SALE 25,000 0.2725 LONG CFD OXFORD BIOMEDICA PLC 10/02/04 SALE 450,000 0.2800 LONG CFD OXFORD BIOMEDICA PLC 10/02/04 SALE 100,000 0.2700 LONG CFD OXFORD BIOMEDICA PLC 10/02/04 SALE 250,000 0.2750 LONG CFD OXFORD BIOMEDICA PLC 06/02/04 SALE 350,000 0.2668 LONG CFD OXFORD BIOMEDICA PLC 06/02/04 SALE 150,000 0.2500 LONG CFD OXFORD BIOMEDICA PLC 06/02/04 SALE 100,000 0.2625 LONG CFD OXFORD BIOMEDICA PLC 06/02/04 SALE 25,000 0.2650 LONG CFD OXFORD BIOMEDICA PLC 05/02/04 SALE 750,000 0.2350 LONG CFD OXFORD BIOMEDICA PLC 05/02/04 SALE 50,000 0.2630 LONG CFD OXFORD BIOMEDICA PLC 05/02/04 SALE 25,000 0.2600 LONG CFD OXFORD BIOMEDICA PLC 04/02/04 SALE 158,000 0.2475 LONG CFD OXFORD BIOMEDICA PLC 02/02/04 SALE 25,000 0.2550 LONG CFD OXFORD BIOMEDICA PLC 23/01/04 SALE 100,000 0.2750 LONG CFD OXFORD BIOMEDICA PLC 22/01/04 SALE 20,000 0.2640 LONG CFD OXFORD BIOMEDICA PLC 21/01/04 SALE 250,000 0.2600 LONG CFD OXFORD BIOMEDICA PLC 21/01/04 SALE 200,000 0.2538 LONG CFD OXFORD BIOMEDICA PLC 08/01/04 SALE 50,000 0.2100 LONG CFD OXFORD BIOMEDICA PLC 17/12/03 SALE 67,609 0.2200 LONG CFD OXFORD BIOMEDICA PLC 11/12/03 SALE 500,000 0.2050 LONG CFD OXFORD BIOMEDICA PLC 10/12/03 SALE 600,000 0.2033 LONG CFD OXFORD BIOMEDICA PLC 03/12/03 SALE 600,000 0.1975 LONG CFD OXFORD BIOMEDICA PLC 27/11/03 SALE 72,989 0.1900 LONG CFD This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Oxford Biomedica